The global Structural Heart Diseases Device market size was valued at US$ 15940 million in 2024 and is forecast to a readjusted size of USD 29460 million by 2031 with a CAGR of 9.3% during review period.
Structural heart devices comprise听annuloplasty rings, heart valve balloons occluders听among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.
The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart"s structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.
This report is a detailed and comprehensive analysis for global Structural Heart Diseases Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Structural Heart Diseases Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Structural Heart Diseases Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Structural Heart Diseases Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Structural Heart Diseases Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Structural Heart Diseases Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Structural Heart Diseases Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Structural Heart Diseases Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
CHD Occluder
Cardioembolic Stroke Occluder
Heart Valve
Other
麻豆原创 segment by Application
Hospitals
Clinics
Major players covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Structural Heart Diseases Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Structural Heart Diseases Device, with price, sales quantity, revenue, and global market share of Structural Heart Diseases Device from 2020 to 2025.
Chapter 3, the Structural Heart Diseases Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Structural Heart Diseases Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Structural Heart Diseases Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Structural Heart Diseases Device.
Chapter 14 and 15, to describe Structural Heart Diseases Device sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Structural Heart Diseases Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 CHD Occluder
1.3.3 Cardioembolic Stroke Occluder
1.3.4 Heart Valve
1.3.5 Other
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Structural Heart Diseases Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.5 Global Structural Heart Diseases Device 麻豆原创 Size & Forecast
1.5.1 Global Structural Heart Diseases Device Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Structural Heart Diseases Device Sales Quantity (2020-2031)
1.5.3 Global Structural Heart Diseases Device Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Structural Heart Diseases Device Product and Services
2.1.4 Abbott Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Abbott Recent Developments/Updates
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Structural Heart Diseases Device Product and Services
2.2.4 Boston Scientific Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Boston Scientific Recent Developments/Updates
2.3 LifeTech
2.3.1 LifeTech Details
2.3.2 LifeTech Major Business
2.3.3 LifeTech Structural Heart Diseases Device Product and Services
2.3.4 LifeTech Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 LifeTech Recent Developments/Updates
2.4 Lepu Medical
2.4.1 Lepu Medical Details
2.4.2 Lepu Medical Major Business
2.4.3 Lepu Medical Structural Heart Diseases Device Product and Services
2.4.4 Lepu Medical Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Lepu Medical Recent Developments/Updates
2.5 Occlutech
2.5.1 Occlutech Details
2.5.2 Occlutech Major Business
2.5.3 Occlutech Structural Heart Diseases Device Product and Services
2.5.4 Occlutech Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Occlutech Recent Developments/Updates
2.6 W. L. Gore & Associates
2.6.1 W. L. Gore & Associates Details
2.6.2 W. L. Gore & Associates Major Business
2.6.3 W. L. Gore & Associates Structural Heart Diseases Device Product and Services
2.6.4 W. L. Gore & Associates Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 W. L. Gore & Associates Recent Developments/Updates
2.7 Starway
2.7.1 Starway Details
2.7.2 Starway Major Business
2.7.3 Starway Structural Heart Diseases Device Product and Services
2.7.4 Starway Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Starway Recent Developments/Updates
2.8 Coherex Medical
2.8.1 Coherex Medical Details
2.8.2 Coherex Medical Major Business
2.8.3 Coherex Medical Structural Heart Diseases Device Product and Services
2.8.4 Coherex Medical Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Coherex Medical Recent Developments/Updates
2.9 Cardia
2.9.1 Cardia Details
2.9.2 Cardia Major Business
2.9.3 Cardia Structural Heart Diseases Device Product and Services
2.9.4 Cardia Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Cardia Recent Developments/Updates
2.10 MicroPort
2.10.1 MicroPort Details
2.10.2 MicroPort Major Business
2.10.3 MicroPort Structural Heart Diseases Device Product and Services
2.10.4 MicroPort Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 MicroPort Recent Developments/Updates
2.11 Edwards Lifesciences
2.11.1 Edwards Lifesciences Details
2.11.2 Edwards Lifesciences Major Business
2.11.3 Edwards Lifesciences Structural Heart Diseases Device Product and Services
2.11.4 Edwards Lifesciences Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Edwards Lifesciences Recent Developments/Updates
2.12 Medtronic
2.12.1 Medtronic Details
2.12.2 Medtronic Major Business
2.12.3 Medtronic Structural Heart Diseases Device Product and Services
2.12.4 Medtronic Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Medtronic Recent Developments/Updates
2.13 Venus Medtech
2.13.1 Venus Medtech Details
2.13.2 Venus Medtech Major Business
2.13.3 Venus Medtech Structural Heart Diseases Device Product and Services
2.13.4 Venus Medtech Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Venus Medtech Recent Developments/Updates
2.14 Meril Life Sciences
2.14.1 Meril Life Sciences Details
2.14.2 Meril Life Sciences Major Business
2.14.3 Meril Life Sciences Structural Heart Diseases Device Product and Services
2.14.4 Meril Life Sciences Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Meril Life Sciences Recent Developments/Updates
2.15 Braile Biomedica
2.15.1 Braile Biomedica Details
2.15.2 Braile Biomedica Major Business
2.15.3 Braile Biomedica Structural Heart Diseases Device Product and Services
2.15.4 Braile Biomedica Structural Heart Diseases Device Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Braile Biomedica Recent Developments/Updates
3 Competitive Environment: Structural Heart Diseases Device by Manufacturer
3.1 Global Structural Heart Diseases Device Sales Quantity by Manufacturer (2020-2025)
3.2 Global Structural Heart Diseases Device Revenue by Manufacturer (2020-2025)
3.3 Global Structural Heart Diseases Device Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Structural Heart Diseases Device by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Structural Heart Diseases Device Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Structural Heart Diseases Device Manufacturer 麻豆原创 Share in 2024
3.5 Structural Heart Diseases Device 麻豆原创: Overall Company Footprint Analysis
3.5.1 Structural Heart Diseases Device 麻豆原创: Region Footprint
3.5.2 Structural Heart Diseases Device 麻豆原创: Company Product Type Footprint
3.5.3 Structural Heart Diseases Device 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Structural Heart Diseases Device 麻豆原创 Size by Region
4.1.1 Global Structural Heart Diseases Device Sales Quantity by Region (2020-2031)
4.1.2 Global Structural Heart Diseases Device Consumption Value by Region (2020-2031)
4.1.3 Global Structural Heart Diseases Device Average Price by Region (2020-2031)
4.2 North America Structural Heart Diseases Device Consumption Value (2020-2031)
4.3 Europe Structural Heart Diseases Device Consumption Value (2020-2031)
4.4 Asia-Pacific Structural Heart Diseases Device Consumption Value (2020-2031)
4.5 South America Structural Heart Diseases Device Consumption Value (2020-2031)
4.6 Middle East & Africa Structural Heart Diseases Device Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Structural Heart Diseases Device Sales Quantity by Type (2020-2031)
5.2 Global Structural Heart Diseases Device Consumption Value by Type (2020-2031)
5.3 Global Structural Heart Diseases Device Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Structural Heart Diseases Device Sales Quantity by Application (2020-2031)
6.2 Global Structural Heart Diseases Device Consumption Value by Application (2020-2031)
6.3 Global Structural Heart Diseases Device Average Price by Application (2020-2031)
7 North America
7.1 North America Structural Heart Diseases Device Sales Quantity by Type (2020-2031)
7.2 North America Structural Heart Diseases Device Sales Quantity by Application (2020-2031)
7.3 North America Structural Heart Diseases Device 麻豆原创 Size by Country
7.3.1 North America Structural Heart Diseases Device Sales Quantity by Country (2020-2031)
7.3.2 North America Structural Heart Diseases Device Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Structural Heart Diseases Device Sales Quantity by Type (2020-2031)
8.2 Europe Structural Heart Diseases Device Sales Quantity by Application (2020-2031)
8.3 Europe Structural Heart Diseases Device 麻豆原创 Size by Country
8.3.1 Europe Structural Heart Diseases Device Sales Quantity by Country (2020-2031)
8.3.2 Europe Structural Heart Diseases Device Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Structural Heart Diseases Device Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Structural Heart Diseases Device Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Structural Heart Diseases Device 麻豆原创 Size by Region
9.3.1 Asia-Pacific Structural Heart Diseases Device Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Structural Heart Diseases Device Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Structural Heart Diseases Device Sales Quantity by Type (2020-2031)
10.2 South America Structural Heart Diseases Device Sales Quantity by Application (2020-2031)
10.3 South America Structural Heart Diseases Device 麻豆原创 Size by Country
10.3.1 South America Structural Heart Diseases Device Sales Quantity by Country (2020-2031)
10.3.2 South America Structural Heart Diseases Device Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Structural Heart Diseases Device Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Structural Heart Diseases Device Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Structural Heart Diseases Device 麻豆原创 Size by Country
11.3.1 Middle East & Africa Structural Heart Diseases Device Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Structural Heart Diseases Device Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Structural Heart Diseases Device 麻豆原创 Drivers
12.2 Structural Heart Diseases Device 麻豆原创 Restraints
12.3 Structural Heart Diseases Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Structural Heart Diseases Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Structural Heart Diseases Device
13.3 Structural Heart Diseases Device Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Structural Heart Diseases Device Typical Distributors
14.3 Structural Heart Diseases Device Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Edwards Lifesciences
Medtronic
Venus Medtech
Meril Life Sciences
Braile Biomedica
听
听
*If Applicable.
